Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Is J&J Going to Sell its Stroke Business?
Medical Devices and Diagnostics Industry
Thu, 02/13/25 - 11:57 am
JNJ
Medtech
stroke
Cerenovus
M&A
Novartis inks $925M Anthos takeover to buy back phase 3 clot-busting candidate
Fierce Biotech
Tue, 02/11/25 - 11:42 am
Novartis
abelacimab
Anthos Therapeutics
M&A
spinoffs
Ten years on, Roche jettisons InterMune and Esbriet in US
Pharmaphorum
Tue, 02/11/25 - 11:08 am
Roche
InterMune
Esbriet
IPF
M&A
Kineta sells Genentech and Merck deals to investor ahead of TuHURA merger
Fierce Biotech
Mon, 02/10/25 - 10:19 am
M&A
Kineta
Genentech
Merck
TuHURA Biosciences
Pacira Pharmaceuticals
Germany's Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say
Marketscreener
Mon, 02/10/25 - 10:16 am
Merck KGaA
M&A
SpringWorks Therapeutics
Bain buys Japanese pharma Mitsubishi Tanabe for $3.4bn
Pharmaphorum
Fri, 02/7/25 - 11:05 am
Bain Capital
M&A
Mitsubishi Tanabe Pharma
Teladoc Health acquires Catapult Health for $65M to boost chronic condition management, at-home testing
Fierce Healthcare
Wed, 02/5/25 - 10:45 pm
Teladoc Health
Catapult Health
telehealth
diagnostics
M&A
Liva buys Momenta to bolster digital health platform
Pharmaphorum
Wed, 02/5/25 - 11:18 am
digital health
Medtech
Liva Healthcare
M&A
Momenta
Pfizer takes $1.2B hit after assessing prospects of Seagen ADCs
Fierce Biotech
Tue, 02/4/25 - 09:55 am
Pfizer
earnings
Seagen
M&A
Lantheus to buy radiopharma CDMO Evergreen Theragnostics for $250M upfront
Medical Marketing and Media
Wed, 01/29/25 - 11:24 am
Lantheus Holdings
radiopharmaceuticals
M&A
Evergreen Theragnostics
Troubled 23andMe is exploring a sale of the business
Pharmaphorum
Wed, 01/29/25 - 11:12 am
23andMe
M&A
Medtech
diagnostics
Sage rejects Biogen's $469 million takeover offer, says offer undervalues company
Yahoo/Reuters
Mon, 01/27/25 - 11:38 am
Biogen
SAGE Therapeutics
M&A
Merck KGaA says high asset prices call for prudent M&A approach
MSN/Reuters
Thu, 01/23/25 - 11:48 am
Merck KGaA
Belén Garijo
M&A
Sage sues Biogen as analyst detects little interest in buyout at original offer price
Fierce Pharma
Tue, 01/21/25 - 07:02 pm
SAGE Therapeutics
legal
Biogen
M&A
zuranolone
By the numbers: J&J, GSK lead J.P. Morgan deal announcements in 2025, the largest turnout in years
Pharma Voice
Thu, 01/16/25 - 11:02 am
JPMHC 2025
M&A
JNJ
Intra-Cellular Therapeutics
GSK
IDRx
Under pressure to deal, Biogen executives deflect urgency at JPM25
BioSpace
Wed, 01/15/25 - 11:33 am
Biogen
JPMHC 2025
M&A
Chris Viehbacher
SAGE Therapeutics
5 questions facing emerging biotech in 2025
BioPharma Dive
Tue, 01/14/25 - 11:22 am
biotech
funding
China
IPOs
cell therapy
gene therapy
M&A
Healthcare dealmakers eye M&A resurgence in second Trump term
US News and World Report
Tue, 01/14/25 - 11:18 am
M&A
JPMHC 2025
Donald Trump
Bayer will focus on debt reduction rather than acquisitions in the coming years
Marketscreener
Tue, 01/14/25 - 11:06 am
Bayer
M&A
J&J to buy psychiatric drug developer Intra-Cellular for $14.6B
BioPharma Dive
Mon, 01/13/25 - 11:19 am
JNJ
Intra-Cellular Therapies
JPMHC 2025
M&A
psychiatric disease
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »